Presence of IBD Specific Antibodies (ASCA, ALCA, ACCA, AMCA) in the Sera of Patients With Spondyloarthropathy
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trials Related to Ankylosing Spondylitis
Related studies linked through entity extraction aliases.
Infliximab and Methotrexate in Ankylosing Spondylitis
- Status
- COMPLETED
- Phase
- PHASE4
An Open-Label Study to Evaluate the Response to Adalimumab in Patients With Active Ankylosing Spondylitis Who Have Failed Standard Therapy or TNF-Alpha Inhibitors (RHAPSODY)
- Status
- COMPLETED
- Phase
- PHASE3
Study Evaluating Etanercept in Patients With Ankylosing Spondylitis
- Status
- COMPLETED
- Phase
- PHASE4
An Open-Label Multicentre Long-Term Extension Study of Etanercept for Ankylosing Spondylitis
- Status
- COMPLETED
- Phase
- PHASE4
Study of Two Schedules of Infliximab Maintenance Therapy in Ankylosing Spondylitis
- Status
- COMPLETED
- Phase
- PHASE3
Study Evaluating Etanercept in the Treatment of Subjects With Ankylosing Spondylitis
- Status
- COMPLETED
- Phase
- PHASE3
Open Label Clinical Trial With Rituximab (MabThera ®) in Ankylosing Spondylitis
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Combination Methotrexate and Infliximab
- Status
- COMPLETED
- Phase
- PHASE4
An Open-Label, Multicentre, Long-Term Extension Study of Etanercept in Ankylosing Spondylitis
- Status
- COMPLETED
- Phase
- PHASE3
Study Evaluating Etanercept Treatment of Patients With Ankylosing Spondylitis
- Status
- COMPLETED
- Phase
- PHASE3
Study Evaluating Etanercept for the Treatment of Active, Severe, and Advanced Axial Ankylosing Spondylitis
- Status
- COMPLETED
- Phase
- PHASE4
Study Comparing Etanercept 50 mg Once Weekly to 25 mg Twice Weekly in Patients With Ankylosing Spondylitis
- Status
- COMPLETED
- Phase
- PHASE3
Extension Study Evaluating Etanercept in Ankylosing Spondylitis
- Status
- COMPLETED
- Phase
- PHASE4
Referral Recommendations for Axial Spondyloarthritis
- Status
- COMPLETED
- Phase
- N/A
Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PN 200 or Naproxen in Subjects Who Are at Risk for Developing NSAID-Associated Ulcers.
- Status
- COMPLETED
- Phase
- PHASE3
16.0040 Ankylosing Spondylitis Study
- Status
- COMPLETED
- Phase
- PHASE3
Study Evaluating the Safety of Etanercept in Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis
- Status
- TERMINATED
- Phase
- N/A
Study Evaluating Etanercept and Sulphasalazine in Ankylosing Spondylitis
- Status
- COMPLETED
- Phase
- PHASE4
Prednisolone in Active Ankylosing Spondylitis (AS)
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3